How Accurate Are Prenatal Screening Tests?

Discover the real accuracy of NIPT and other prenatal screening tests in 2026. Learn what detection rates mean for US pregnancies and how to order a comprehensive panel.

Prenatal screening tests, especially non-invasive prenatal testing (NIPT) using cell-free DNA, are highly accurate for detecting common chromosomal conditions such as trisomy 21 (Down syndrome), trisomy 18, and trisomy 13. In 2026, NIPT continues to offer a detection rate greater than 99% for these trisomies, with a very low false-positive rate of less than 0.1%. But accuracy varies by test type, the condition being screened, and factors like fetal fraction. This guide explains the different types of prenatal screening, their real-world accuracy, and what every US parent should know before deciding to test.

Understanding Prenatal Screening vs. Diagnostic Testing

Prenatal screening tests estimate the risk that a baby has a genetic condition. They do not diagnose. Diagnostic tests like chorionic villus sampling (CVS) and amniocentesis provide a definitive answer but carry a small risk of miscarriage. Screening tests are safe, non-invasive, and designed to guide next steps.

Non-Invasive Prenatal Testing (NIPT) – The Gold Standard

NIPT analyzes cell-free DNA from the placenta circulating in the mother’s blood. It can be performed as early as 10 weeks of pregnancy. In 2026, lab improvements have pushed its accuracy even higher.

What NIPT Screens For

Trisomy 21 (Down syndrome): detection rate >99%, false-positive rate <0.1%
Trisomy 18 (Edwards syndrome): detection rate ~97%
Trisomy 13 (Patau syndrome): detection rate ~95%
Sex chromosome aneuploidies: detection rates vary by condition (e.g., 90–95% for Turner syndrome)
Fetal sex: >99% accurate after 10 weeks

Factors That Affect NIPT Accuracy

Accuracy depends on fetal fraction — the percentage of cell-free DNA from the placenta in the mother’s blood. A fetal fraction below 4% may lead to a failed test or a false result. Other factors include maternal weight (higher BMI can lower fetal fraction), twin pregnancies, and vanishing twin syndrome. Always discuss results with a genetic counselor.

Other Types of Prenatal Screening Tests

First-Trimester Screening

This combines a blood test (measuring PAPP-A and hCG) with a nuchal translucency ultrasound. It detects about 85% of Down syndrome cases, with a 5% false-positive rate. It is less accurate than NIPT but often used as an initial screen.

Quad Screen (Second-Trimester Screening)

Performed between 15 and 20 weeks, the quad screen measures four markers (AFP, hCG, estriol, inhibin A). It detects about 80% of Down syndrome and 75% of neural tube defects (like spina bifida), with a 5% false-positive rate.

Integrated Screening

Combines first-trimester and second-trimester blood tests and ultrasound into a single risk estimate. It can detect ~90–95% of Down syndrome, with a lower false-positive rate than either test alone.

Carrier Screening: A Separate Category

Carrier screening checks whether a parent carries a gene for a recessive condition (e.g., cystic fibrosis, spinal muscular atrophy, fragile X syndrome). It is not a screening test for the baby’s chromosomes, but it is often offered alongside NIPT. Carrier screening is highly accurate for the specific mutations tested (>99% for common mutations), but it does not detect all possible variants. A negative result greatly reduces — but does not eliminate — the chance of being a carrier.

Accuracy Comparison Table

Test Type	Condition Screened	Detection Rate	False-Positive Rate
NIPT (cell-free DNA)	Trisomy 21	>99%	<0.1%
NIPT (cell-free DNA)	Trisomy 18	~97%	<0.1%
First-Trimester Screen	Trisomy 21	~85%	~5%
Quad Screen	Trisomy 21	~80%	~5%
Integrated Screen	Trisomy 21	~90–95%	~2%

When to Consider Diagnostic Testing

If a screening test returns a high-risk result, a genetic counselor will typically recommend a diagnostic test — either chorionic villus sampling (CVS) at 10–13 weeks or amniocentesis at 15–20 weeks. Both are >99% accurate for chromosomal conditions but carry a small risk of miscarriage (roughly 1 in 500 to 1 in 1,000 for amniocentesis in experienced centers).

Frequently Asked Questions

Can NIPT give a false negative?

Yes, though rare. False negatives can occur if the fetal fraction is too low, if the placenta has a different genetic makeup than the baby (confined placental mosaicism), or if the condition is present in only a small percentage of cells (mosaicism).

Does insurance cover prenatal screening?

Most US insurance plans, including Medicaid, cover NIPT for high-risk pregnancies. Many now cover it for all pregnancies. Check with your provider. Out-of-pocket costs typically range from a few hundred to about a thousand dollars, but many labs offer self-pay rates around $200–$400.

Can a prenatal screening test determine paternity?

Yes, a prenatal paternity test can be done using cell-free DNA from the mother’s blood after 9 weeks of pregnancy. It is not part of standard NIPT panels and must be ordered separately.

Making Your Choice

Understanding the accuracy of each prenatal screening test helps you make an informed decision. NIPT offers the highest accuracy for common trisomies, while carrier screening adds critical information about recessive conditions. Speak with your healthcare provider or a genetic counselor to decide which tests are right for your pregnancy.

If you are ready to take the next step, you can order a comprehensive prenatal screening panel online from a trusted US laboratory. Results are typically available within 5–7 business days, giving you peace of mind early in your pregnancy.